TSP7-DrugMatrix - Toxicogenomic signatures after exposure to daunorubicin in the rat


TSA15-DrugMatrix - Toxicogenomic signatures of Liver after exposure to daunorubicin (3.25 mg/kg, 1 days) in the rat


TSA16-DrugMatrix - Toxicogenomic signatures of Liver after exposure to daunorubicin (3.25 mg/kg, 3 days) in the rat


TSA17-DrugMatrix - Toxicogenomic signatures of Kidney after exposure to daunorubicin (3.25 mg/kg, 5 days) in the rat


TSA18-DrugMatrix - Toxicogenomic signatures of Kidney after exposure to daunorubicin (3.25 mg/kg, 3 days) in the rat


TSA19-DrugMatrix - Toxicogenomic signatures of Heart after exposure to daunorubicin (2 mg/kg, 3 days) in the rat


TSA20-DrugMatrix - Toxicogenomic signatures of Heart after exposure to daunorubicin (2 mg/kg, 5 days) in the rat


TSA21-DrugMatrix - Toxicogenomic signatures of Heart after exposure to daunorubicin (3.25 mg/kg, 3 days) in the rat


TSA22-DrugMatrix - Toxicogenomic signatures of Heart after exposure to daunorubicin (2 mg/kg, 1 days) in the rat


TSA23-DrugMatrix - Toxicogenomic signatures of Heart after exposure to daunorubicin (3.25 mg/kg, 1 days) in the rat


TSA24-DrugMatrix - Toxicogenomic signatures of Heart after exposure to daunorubicin (3.25 mg/kg, 5 days) in the rat


TSF15-daunorubicin


1 subfactor(s)
TSF16-daunorubicin


1 subfactor(s)
TSF17-daunorubicin


1 subfactor(s)
TSF18-daunorubicin


1 subfactor(s)
TSF19-daunorubicin


1 subfactor(s)
TSF20-daunorubicin


1 subfactor(s)
TSF21-daunorubicin


1 subfactor(s)
TSF22-daunorubicin


1 subfactor(s)
TSF23-daunorubicin


1 subfactor(s)
TSF24-daunorubicin


1 subfactor(s)
TSS15-DrugMatrix - Toxicogenomic signatures of Liver after exposure to daunorubicin (3.25 mg/kg, 1 days) in the rat


TSS16-DrugMatrix - Toxicogenomic signatures of Liver after exposure to daunorubicin (3.25 mg/kg, 3 days) in the rat


TSS17-DrugMatrix - Toxicogenomic signatures of Kidney after exposure to daunorubicin (3.25 mg/kg, 5 days) in the rat


TSS18-DrugMatrix - Toxicogenomic signatures of Kidney after exposure to daunorubicin (3.25 mg/kg, 3 days) in the rat


TSS19-DrugMatrix - Toxicogenomic signatures of Heart after exposure to daunorubicin (2 mg/kg, 3 days) in the rat


TSS20-DrugMatrix - Toxicogenomic signatures of Heart after exposure to daunorubicin (2 mg/kg, 5 days) in the rat


TSS21-DrugMatrix - Toxicogenomic signatures of Heart after exposure to daunorubicin (3.25 mg/kg, 3 days) in the rat


TSS22-DrugMatrix - Toxicogenomic signatures of Heart after exposure to daunorubicin (2 mg/kg, 1 days) in the rat


TSS23-DrugMatrix - Toxicogenomic signatures of Heart after exposure to daunorubicin (3.25 mg/kg, 1 days) in the rat


TSS24-DrugMatrix - Toxicogenomic signatures of Heart after exposure to daunorubicin (3.25 mg/kg, 5 days) in the rat



TSP7 - DrugMatrix - Toxicogenomic signatures after exposure to daunorubicin in the rat Public

DrugMatrix is the scientific communities' largest molecular toxicology reference database and informatics system. DrugMatrix is populated with the comprehensive results of thousands of highly controlled and standardized toxicological experiments in which rats or primary rat hepatocytes were systematically treated with therapeutic, industrial, and environmental chemicals at both non-toxic and toxic doses.

Interventional Experimental design

No experimental design provided

Results

No results provided